• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Herbalife Ltd. filed SEC Form 8-K: Entry into a Material Definitive Agreement

    4/18/24 4:08:08 PM ET
    $HLF
    Other Pharmaceuticals
    Health Care
    Get the next $HLF alert in real time by email
    8-K
    false 0001180262 0001180262 2024-04-12 2024-04-12

     

     

    UNITED STATES

    SECURITIES AND EXCHANGE COMMISSION

    WASHINGTON, D.C. 20549

     

     

    FORM 8-K

     

     

    CURRENT REPORT

    Pursuant to Section 13 or 15(d)

    of the Securities Exchange Act of 1934

    Date of report (Date of earliest event reported): April 12, 2024

     

     

    Herbalife Ltd.

    (Exact Name of Registrant as Specified in Charter)

     

     

     

    Cayman Islands   1-32381   98-0377871

    (State or Other Jurisdiction

    of Incorporation)

     

    (Commission

    File Number)

     

    (IRS Employer

    Identification No.)

    P.O. Box 309, Ugland House  
    Grand Cayman  
    Cayman Islands   KY1-1104
    (Address of Principal Executive Offices)   (Zip Code)

    Registrant’s telephone number, including area code: c/o (213) 745-0500

    Not Applicable

    (Former Name or Former Address, if Changed Since Last Report)

     

     

    Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

     

    ☐

    Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

     

    ☐

    Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

     

    ☐

    Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

     

    ☐

    Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

    Securities registered pursuant to Section 12(b) of the Act:

     

    Title of each class

     

    Trading
    Symbol(s)

     

    Name of each exchange

    on which registered

    Common Shares, par value $0.0005 per share   HLF   New York Stock Exchange

    Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).

    Emerging growth company ☐

    If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

     

     

     


    Item 1.01

    Entry into a Material Definitive Agreement.

    Senior Secured Notes due 2029

    On April 12, 2024, HLF Financing SaRL, LLC (“HLF Financing”) and Herbalife International, Inc. (“HII” and together with HLF Financing, the “Issuers”), each a wholly owned subsidiary of Herbalife Ltd., a Cayman Islands exempted company incorporated with limited liability (the “Company”), issued $800 million aggregate principal amount of 12.250% Senior Secured Notes due 2029 (the “Notes”) to certain initial purchasers (the “Offering”). The Notes were offered and sold in the United States to persons reasonably believed to be qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended (the “Securities Act”), and outside the United States pursuant to Regulation S under the Securities Act. The Notes are governed by an indenture, dated as of April 12, 2024, among the Issuers, the Company and certain subsidiaries of the Company party thereto as guarantors and Citibank, N.A., as trustee and notes collateral agent (the “Indenture”).

    The Notes will bear interest at a rate of 12.250% per year payable semi-annually in arrears in cash on April 15 and October 15 of each year, beginning on October 15, 2024. The Notes will mature on April 15, 2029.

    The Notes are jointly and severally, unconditionally guaranteed on a senior secured basis by the Company and its existing and future subsidiaries that are guarantors of the obligations of any domestic borrower under the Company’s senior secured credit facility. The Notes and the related guarantees are the Issuers’ and the guarantors’ senior obligations, and are secured on a pari passu first-priority basis by liens on the Collateral (as defined in the Indenture), which is the same collateral that secures the Company’s senior secured credit facility, subject to certain limitations and permitted liens, and are: (i) equal in right of payment with all of the Issuers’ and guarantors’ existing and future senior indebtedness; (ii) equal in priority as to the Collateral owned by the Issuers and guarantors with respect to any obligations of the Issuers and guarantors secured by a first priority lien on the Collateral, including under the Company’s senior secured credit facility; (iii) effectively senior to all existing and future indebtedness of the Issuers and guarantors that is unsecured or secured by junior liens on the Collateral, to the extent of the value of the Collateral owned by the Issuers or such guarantor; (iv) effectively subordinated to all of the Issuers’ and guarantors’ existing and future indebtedness that is secured by liens on assets that do not constitute a part of the Collateral, to the extent of the value of such assets; and (v) senior in right of payment to any of the Issuers’ future indebtedness that is, by its terms, expressly subordinated in right of payment to the Notes.

    At any time prior to April 15, 2026, the Issuers may redeem all or part of the Notes at a redemption price equal to 100% of their principal amount, plus a “make whole” premium as of the redemption date, and accrued and unpaid interest (subject to the rights of holders of record on the relevant record date to receive interest due on the relevant interest payment date). In addition, at any time prior to April 15, 2026, the Issuers may redeem up to 40% of the aggregate principal amount of the Notes with the proceeds of one or more equity offerings, at a redemption price equal to 112.250%, plus accrued and unpaid interest. Furthermore, at any time on or after April 15, 2026, the Issuers may redeem all or part of the Notes at the following redemption prices, expressed as percentages of principal amount, plus accrued and unpaid interest thereon to the redemption date, if redeemed during the twelve-month period beginning on April 15, of the years indicated below:

     

    Year    Percentage  

    2026

         106.125 % 

    2027

         103.063 % 

    2028 and thereafter

         100.000 % 

    The Indenture contains customary negative covenants, including, among other things, limitations or prohibitions on restricted payments, incurrence of additional indebtedness, liens, mergers, asset sales and transactions with affiliates. In addition, the Indenture contains customary events of default.

    The foregoing summary of the Indenture is not complete and is qualified in its entirety by reference to the complete text of the Indenture, which includes the form of the Note, a copy of which is filed as Exhibit 4.1 hereto and is incorporated herein by reference.


    Senior Secured Credit Facility

    On April 12, 2024, the Company, HLF Financing, HII, Herbalife International Luxembourg S.à R.L., HBL IHB Operations S.à r.l., certain subsidiaries of the Company party thereto as guarantors, the lenders party thereto, each issuing bank, Jefferies Finance LLC, as administrative agent for the lenders under the term loan B facility (the “Term B Facility”) and as collateral agent, and Coöperatieve Rabobank U.A., New York Branch (“Rabobank”), as administrative agent for the lenders under the revolving credit facility (the “Revolving Credit Facility”, and together with the Term B Facility, the “Credit Facilities”), entered into an eighth amendment (the “Amendment”) to the Credit Agreement dated as of August 16, 2018 (as so amended, the “Credit Agreement”).

    The Amendment, among other things, refinanced and replaced in full the Company’s existing credit facilities with (i) the Term B Facility, with an aggregate principal amount of $400 million, and (ii) the Revolving Credit Facility, with an aggregate principal amount of $400 million (the refinancings effected pursuant to the Credit Agreement, together with the Offering, the “Refinancings”).

    The Term B Facility bears interest at either Adjusted Term SOFR plus a margin of 6.75%, or base rate plus a margin of 5.75%. The Term B Facility matures on April 12, 2029, subject to a springing maturity 91 days ahead of certain other indebtedness of the Company unless certain conditions are met.

    Borrowings under the Revolving Credit Facility will bear interest, depending on the Company’s total leverage ratio, at either Adjusted Term SOFR plus a margin of between 5.50% and 6.50%, or base rate plus a margin of between 4.50% and 5.50%. The Company will pay a commitment fee on the undrawn portion of the Revolving Facility of, depending on the Company’s total leverage ratio, between 0.35% to 0.45% per annum. The Revolving Credit Facility matures on April 12, 2028, subject to a springing maturity 182 days ahead of certain other indebtedness of the Company unless certain conditions are met.

    The Credit Agreement contains affirmative, negative and financial covenants customary for financings of this type, including, among other things, limitations or prohibitions on declaring and paying dividends and other distributions, redeeming and repurchasing certain other indebtedness, loans and investments, additional indebtedness, liens, mergers, asset sales and transactions with affiliates. In addition, the Credit Agreement contains customary events of default. The Revolving Credit Facility requires the Company to comply with certain financial covenants, including (i) a maximum total leverage ratio of 4.50:1.00 through December 31, 2024, stepping down to 4.25:1.00 on March 31, 2025 and 4.00:1.00 at September 30, 2025 and thereafter, (ii) a maximum first lien net leverage ratio of 2.50:1.00, (iii) a minimum fixed charge coverage ratio of 2.00:1.00, and (iv) a minimum liquidity coverage of $200 million of revolver availability and accessible cash.

    The Credit Facilities are jointly and severally, unconditionally guaranteed on a senior secured basis by the Company and certain of its existing and future subsidiaries.

    The foregoing summary of the Amendment is not complete and is qualified in its entirety by reference to the complete text of the Amendment a copy of which is filed as Exhibit 10.1 hereto and is incorporated herein by reference.

     

    Item 2.03

    Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant.

    The information set forth under “Item 1.01. Entry into a Material Definitive Agreement” is incorporated herein by reference.

     

    Item 2.04

    Triggering Events That Accelerate or Increase a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement.

    On April 4, 2024, the Company and HLF Financing, Inc. issued a conditional notice of redemption to redeem $300 million aggregate principal amount of its outstanding 7.875% Senior Notes due 2025 (the “2025 Notes”), subject to satisfaction or waiver by the Company of the condition that certain subsidiaries of the Company completed an


    offering of at least $700 million aggregate principal amount of senior secured debt securities. The closing of the Offering on April 12, 2024 satisfied the condition precedent set forth in the notice of redemption such that the redemption is expected to occur on April 19, 2024. The 2025 Notes were issued under an Indenture, dated as of August 16, 2018, among the Company, HLF Financing, Inc., U.S. Bank Trust Company, National Association (as successor to MUFG Union Bank, N.A.), as Trustee (as defined therein) and the guarantors party thereto (the “2025 Notes Indenture”). The redemption price for the 2025 Notes is equal to 101.969% of the principal amount plus accrued and unpaid interest to, but not including the Redemption Date estimated to be an aggregate of approximately $3.2 million.

     

    Item 8.01.

    Other Events.

    On April 12, 2024, the Company issued a press release announcing the closing of the Refinancings.

    A copy of the press release is attached hereto as Exhibit 99.1 and incorporated herein by reference.

     

    Item 9.01

    Financial Statements and Exhibits.

    (d) Exhibits.

     

     4.1    Indenture, dated as of April 12, 2024 among HLF Financing SaRL, LLC and Herbalife International, Inc., the guarantors party thereto and Citibank, N.A., as trustee and notes collateral agent.
     4.2    Form of Global Note for 12.250% Senior Secured Notes due 2029 (included as Exhibit A to Exhibit 4.1 hereto).
    10.1    Eighth Amendment to Credit Agreement, dated as of April 12, 2024, by and among HLF Financing SaRL, LLC., Herbalife Ltd., Herbalife International Luxembourg S.à R.L., HBL IHB Operations S.à r.l., Herbalife International, Inc., certain of Herbalife Ltd.’s subsidiaries party thereto as subsidiary guarantors, the several banks and other financial institutions or entities party thereto as lenders, Jefferies Finance LLC, as administrative agent for the Term Loan B Lenders and as collateral agent and Coöperatieve Rabobank U.A., New York Branch, as administrative agent for the Revolving Credit Lenders.
    99.1    Press Release issued by Herbalife Ltd. on April 12, 2024.
    104    Cover Page Interactive Data File - The cover page from the Company’s Current Report on Form 8-K filed on April 18, 2024 is formatted in Inline XBRL (included as Exhibit 101).


    SIGNATURES

    Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

     

        Herbalife Ltd.
    April 18, 2024     By:  

    /s/ Henry Wang

        Name:   Henry Wang
        Title:  

    Executive Vice President, General

    Counsel and Corporate Secretary

    Get the next $HLF alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $HLF

    DatePrice TargetRatingAnalyst
    1/6/2026$20.00Buy
    Maxim Group
    11/26/2025Hold → Buy
    Argus
    3/21/2025$7.50 → $14.00Neutral → Buy
    DA Davidson
    8/1/2024$16.00 → $17.00Buy
    B. Riley Securities
    9/14/2023$13.50Neutral
    DA Davidson
    6/7/2023$13.00Neutral
    Mizuho
    2/3/2023$14.00Underperform
    BofA Securities
    7/12/2022$26.00Hold → Buy
    Jefferies
    More analyst ratings

    $HLF
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Herbalife to Announce Fourth Quarter and Full-Year 2025 Results on February 18

    Herbalife Ltd. (NYSE:HLF), a premier health and wellness company, community and platform, will release its fourth quarter and full-year 2025 financial results after the close of trading on the NYSE on Wednesday, February 18, 2026. On the same day, at 5:30 p.m. ET (2:30 p.m. PT), Herbalife's senior management team will host an audio webcast and conference call to discuss its recent financial results. The audio webcast will be available at the following link: https://edge.media-server.com/mmc/p/si6puiij Participants joining via the conference call may obtain the dial-in information and personal PIN to access the call by registering at the following link: https://register-conf.media-server

    1/5/26 7:05:00 AM ET
    $HLF
    Other Pharmaceuticals
    Health Care

    Herbalife CFO Fireside Chat Webcast from Furey Research Partners Hidden Gems Conference Available

    Herbalife Ltd. (NYSE:HLF), a premier health and wellness company, community and platform, today announced John DeSimone, Chief Financial Officer, participated in a fireside chat at the Furey Research Partners Hidden Gems Conference on Monday, November 24. The webcast is now available under the Investor Relations section of Herbalife's website at https://ir.herbalife.com/ and will remain accessible for six months. For more information about Furey Research Partners, please visit https://www.fureyresearch.com/. About Herbalife Ltd. Herbalife (NYSE:HLF) is a premier health and wellness company, community and platform that has been changing people's lives with great nutrition products and a

    11/25/25 7:05:00 AM ET
    $HLF
    Other Pharmaceuticals
    Health Care

    Herbalife CEO and CFO to Participate in BofA Securities Leveraged Finance Conference on December 2

    Herbalife Ltd. (NYSE:HLF), a premier health and wellness company, community and platform, today announced Stephan Gratziani, Chief Executive Officer and John DeSimone, Chief Financial Officer, will participate in a fireside chat at the BofA Securities Leveraged Finance Conference on Tuesday, December 2, 2025 at 8:10 a.m. ET (5:10 a.m. PT). A link to the live webcast will be available under the Investor Relations section of Herbalife's website at https://ir.herbalife.com/. A replay of the webcast will also be available at the same website following the completion of the event and for six months thereafter. About Herbalife Ltd. Herbalife (NYSE:HLF) is a premier health and wellness compa

    11/19/25 7:05:00 AM ET
    $HLF
    Other Pharmaceuticals
    Health Care

    $HLF
    SEC Filings

    View All

    Amendment: SEC Form SCHEDULE 13G/A filed by Herbalife Ltd.

    SCHEDULE 13G/A - HERBALIFE LTD. (0001180262) (Subject)

    2/12/26 2:14:18 PM ET
    $HLF
    Other Pharmaceuticals
    Health Care

    Herbalife Ltd. filed SEC Form 8-K: Results of Operations and Financial Condition, Regulation FD Disclosure

    8-K - HERBALIFE LTD. (0001180262) (Filer)

    11/5/25 4:27:57 PM ET
    $HLF
    Other Pharmaceuticals
    Health Care

    SEC Form 10-Q filed by Herbalife Ltd.

    10-Q - HERBALIFE LTD. (0001180262) (Filer)

    11/5/25 4:18:28 PM ET
    $HLF
    Other Pharmaceuticals
    Health Care

    $HLF
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Maxim Group initiated coverage on Herbalife Nutrition with a new price target

    Maxim Group initiated coverage of Herbalife Nutrition with a rating of Buy and set a new price target of $20.00

    1/6/26 9:08:50 AM ET
    $HLF
    Other Pharmaceuticals
    Health Care

    Herbalife Nutrition upgraded by Argus

    Argus upgraded Herbalife Nutrition from Hold to Buy

    11/26/25 7:50:23 AM ET
    $HLF
    Other Pharmaceuticals
    Health Care

    Herbalife Nutrition upgraded by DA Davidson with a new price target

    DA Davidson upgraded Herbalife Nutrition from Neutral to Buy and set a new price target of $14.00 from $7.50 previously

    3/21/25 8:38:07 AM ET
    $HLF
    Other Pharmaceuticals
    Health Care

    $HLF
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 4 filed by Herbalife Ltd.

    4 - HERBALIFE LTD. (0001180262) (Issuer)

    12/1/25 9:00:53 PM ET
    $HLF
    Other Pharmaceuticals
    Health Care

    Director Cloud Lynda bought $152,490 worth of shares (17,000 units at $8.97), increasing direct ownership by 78% to 38,857 units (SEC Form 4)

    4 - HERBALIFE LTD. (0001180262) (Issuer)

    11/20/25 8:41:01 PM ET
    $HLF
    Other Pharmaceuticals
    Health Care

    SEC Form 4 filed by Chief Commercial Officer Lamberti Frank

    4 - HERBALIFE LTD. (0001180262) (Issuer)

    11/18/25 6:37:50 PM ET
    $HLF
    Other Pharmaceuticals
    Health Care

    $HLF
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Cloud Lynda bought $152,490 worth of shares (17,000 units at $8.97), increasing direct ownership by 78% to 38,857 units (SEC Form 4)

    4 - HERBALIFE LTD. (0001180262) (Issuer)

    11/20/25 8:41:01 PM ET
    $HLF
    Other Pharmaceuticals
    Health Care

    Director Mendoza Juan Miguel bought $23,572 worth of shares (3,143 units at $7.50), increasing direct ownership by 2% to 170,000 units (SEC Form 4)

    4 - HERBALIFE LTD. (0001180262) (Issuer)

    6/9/25 6:00:12 PM ET
    $HLF
    Other Pharmaceuticals
    Health Care

    Director Mendoza Juan Miguel bought $33,750 worth of shares (5,000 units at $6.75), increasing direct ownership by 3% to 166,857 units (SEC Form 4)

    4 - HERBALIFE LTD. (0001180262) (Issuer)

    5/23/25 4:01:25 PM ET
    $HLF
    Other Pharmaceuticals
    Health Care

    $HLF
    Leadership Updates

    Live Leadership Updates

    View All

    Herbalife Welcomes Lynda Cloud to its Board of Directors

    Herbalife Ltd. (NYSE:HLF), a premier health and wellness company, community and platform, today announced the election of Lynda Cloud to its Board of Directors, effective April 23, 2025. This appointment reflects Herbalife's continued commitment to innovation, digital transformation, and personalized wellness. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250425107883/en/Herbalife Welcomes Lynda Cloud to the Board of Directors Lynda Cloud's decades of leadership across education, technology, and health sectors make her uniquely equipped to support Herbalife's next chapter. Her deep expertise in digital learning, consumer experie

    4/25/25 5:12:00 PM ET
    $HLF
    Other Pharmaceuticals
    Health Care

    Herbalife Appoints Stephan Gratziani as Chief Executive Officer

    Current CEO Michael Johnson Transitions to Executive Chairman Herbalife Ltd. (NYSE:HLF) today announced its Board of Directors has appointed President, Stephan Gratziani as Chief Executive Officer (CEO) effective May 1, 2025. Michael Johnson, current CEO and Chairman of the Board, will transition to Executive Chairman. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250219653469/en/Herbalife appoints Stephan Gratziani as Chief Executive Officer (Photo: Business Wire) As a former Herbalife independent distributor, Mr. Gratziani built and grew his international business into one of the top global distributorships. For 32 years, he

    2/19/25 4:05:00 PM ET
    $HLF
    Other Pharmaceuticals
    Health Care

    Herbalife Expands Board of Directors with Appointment of Perkins Miller

    Herbalife Ltd. (NYSE:HLF), a premier health and wellness company, community and platform, today welcomed experienced e-commerce and media technology executive Perkins Miller to its board of directors. Miller's appointment as an independent director is effective June 26, 2024. "Perkins brings valuable, proven expertise in leading large-scale e-commerce, technology and sports enterprises, which will be a great asset to our Board as the Company continues to grow and transform," said Michael Johnson, Chairman and CEO of Herbalife. Miller is the CEO of Fandom, the world's largest fan platform where fans immerse themselves in imagined worlds across entertainment and gaming, where he has trans

    6/26/24 7:05:00 AM ET
    $HLF
    Other Pharmaceuticals
    Health Care

    $HLF
    Financials

    Live finance-specific insights

    View All

    Herbalife to Announce Fourth Quarter and Full-Year 2025 Results on February 18

    Herbalife Ltd. (NYSE:HLF), a premier health and wellness company, community and platform, will release its fourth quarter and full-year 2025 financial results after the close of trading on the NYSE on Wednesday, February 18, 2026. On the same day, at 5:30 p.m. ET (2:30 p.m. PT), Herbalife's senior management team will host an audio webcast and conference call to discuss its recent financial results. The audio webcast will be available at the following link: https://edge.media-server.com/mmc/p/si6puiij Participants joining via the conference call may obtain the dial-in information and personal PIN to access the call by registering at the following link: https://register-conf.media-server

    1/5/26 7:05:00 AM ET
    $HLF
    Other Pharmaceuticals
    Health Care

    Herbalife to Announce Third Quarter 2025 Results on November 5

    Herbalife Ltd. (NYSE:HLF), a premier health and wellness company, community and platform, will release its third quarter 2025 financial results after the close of trading on the NYSE on Wednesday, November 5, 2025. On the same day, at 5:30 p.m. ET (2:30 p.m. PT), Herbalife's senior management team will host an audio webcast and conference call to discuss its recent financial results. The audio webcast will be available at the following link: https://edge.media-server.com/mmc/p/4btutrtf Participants joining via the conference call may obtain the dial-in information and personal PIN to access the call by registering at the following link: https://register-conf.media-server.com/register/BI

    10/1/25 7:05:00 AM ET
    $HLF
    Other Pharmaceuticals
    Health Care

    Herbalife Reports Q2 Net Sales Near Guidance Midpoint; Q2 Adjusted EBITDA1 Exceeds Guidance; Raises Net Sales and Adjusted EBITDA1 Full-Year Guidance

    Highlights MultiBurn™ Launch and Unveiling of Beta Version of Pro2col App and Healthy Lifespan Supplement Herbalife Ltd. (NYSE:HLF) today reported financial results for the second quarter ended June 30, 2025: This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250806517228/en/ "Herbalife is entering a pivotal new era. The beta release of our AI-assisted Pro2col™ app at our North America Extravaganza, with over 7,000 distributors joining this early access phase, marks a bold and powerful first step." - Stephan Gratziani, CEO Highlights Second Quarter 2025 Net sales of $1.3 billion near midpoint of guidance range Down 1.7% vs.

    8/6/25 4:10:00 PM ET
    $HLF
    Other Pharmaceuticals
    Health Care

    $HLF
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by Herbalife Ltd.

    SC 13G/A - HERBALIFE LTD. (0001180262) (Subject)

    11/14/24 4:11:11 PM ET
    $HLF
    Other Pharmaceuticals
    Health Care

    SEC Form SC 13G filed by Herbalife Ltd.

    SC 13G - HERBALIFE LTD. (0001180262) (Subject)

    11/13/24 4:01:31 PM ET
    $HLF
    Other Pharmaceuticals
    Health Care

    Amendment: SEC Form SC 13G/A filed by Herbalife Ltd.

    SC 13G/A - HERBALIFE LTD. (0001180262) (Subject)

    11/13/24 12:49:27 PM ET
    $HLF
    Other Pharmaceuticals
    Health Care